DERMOSCRIBE ICHYBUM- hydrocortisone, clioquinol, zinc oxide cream

国家: 美国

语言: 英文

来源: NLM (National Library of Medicine)

现在购买

下载 产品特点 (SPC)
03-10-2023

有效成分:

HYDROCORTISONE (UNII: WI4X0X7BPJ) (HYDROCORTISONE - UNII:WI4X0X7BPJ), CLIOQUINOL (UNII: 7BHQ856EJ5) (CLIOQUINOL - UNII:7BHQ856EJ5)

可用日期:

DERMOSCRIBE PTY LTD

给药途径:

TOPICAL

处方类型:

OTC DRUG

疗效迹象:

PURPOSE ANAL ITCHING DERMOSCRIBE'S ICHYBUM ANAL ITCHING CREAM IS A TOPICAL TREATMENT FOR RELIEF OF THE SYMPTOMS OF PRURITUS ANI AND OTHER AFFLICTIONS INVOLVING CHRONIC ITCHING AROUND THE ANUS.

授权状态:

OTC monograph not final

产品特点

                                DERMOSCRIBE ICHYBUM- HYDROCORTISONE, CLIOQUINOL, ZINC OXIDE CREAM
DERMOSCRIBE PTY LTD
_Disclaimer: Most OTC drugs are not reviewed and approved by FDA,
however they may_
_be marketed if they comply with applicable regulations and policies.
FDA has not_
_evaluated whether this product complies._
----------
DERMOSCRIBE (AS PLD) - ICHYBUM CREAM (69683-101)
CONTAINS: HYDROCORTISONE 1%, CLIOQUINOL 1%, ZINC OXIDE CREAM
PURPOSE
ANAL ITCHING
DERMOSCRIBE'S ICHYBUM ANAL ITCHING CREAM IS A TOPICAL TREATMENT FOR
RELIEF OF THE SYMPTOMS OF PRURITUS ANI AND OTHER AFFLICTIONS INVOLVING
CHRONIC ITCHING AROUND THE ANUS.
WARNINGS
FOR EXTERNAL USE ONLY
USE ONLY IN ACCORDANCE WITH DIRECTIONS ON LABEL AND WITHIN THE
PACKAGING. SEEK MEDICAL ADVICE IF PREGNANT OR BREASTFEEDING. AVOID
EYES.
DO NOT SWALLOW. CONSULT A HEALTHCARE PROFESSIONAL ABOUT LONG TERM
USE. IF IRRITATION DEVELOPS, SEEK MEDICAL ADVICE. MAY NOT BE AS
EFFECTIVE
BEYOND EXPIRY DATE. REFER TO ENCLOSED LEAFLET FOR DETAILED DIRECTIONS.
KEEP OUT OF REACH OF CHILDREN.
DIRECTIONS
•FOR USE ONLY BY ADULTS AND CHILDREN OVER 12 YEARS.
•APPLY A SMALL AMOUNT IN A THIN LAYER OVER THE AFFECTED AREA ONCE OR
TWICE DAILY AS REQUIRED, PREFERABLY AFTER SHOWERING AND/OR BOWEL
MOVEMENTS AS WELL AS AT NIGHT BEFORE SLEEP.
INACTIVE INGREDIENTS
ZINC OXIDE, WATER
STORE AT ROOM TEMPERATURE
DERMOSCRIBE ICHYBUM
hydrocortisone, clioquinol, zinc oxide cream
PRODUCT INFORMATION
PRODUCT TYPE
HUMAN OTC DRUG
ITEM CODE (SOURCE)
NDC:69683-101
ROUTE OF ADMINISTRATION
TOPICAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRENGTH
HYDROCORTISONE (UNII: WI4X0X7BPJ) (HYDROCORTISONE - UNII:WI4X0X7BPJ)
HYDROCORTISONE
1 g in 100 g
CLIOQUINOL (UNII: 7BHQ856EJ5) (CLIOQUINOL - UNII:7BHQ856EJ5)
CLIOQUINOL
1 g in 100 g
INACTIVE INGREDIENTS
INGREDIENT NAME
STRENGTH
ZINC OXIDE (UNII: SOI2LOH54Z)
WATER (UNII: 059QF0KO0R)
PACKAGING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END
DATE
DERMOSCRIBE PTY LTD
1
NDC:69683-101-
11
28 g in 1 BOTTLE; Type 0: Not a Combination
Product
03/23/201
                                
                                阅读完整的文件